FNY Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
FNY Investment Advisers's BMY Position: Q1 2026 in Review
FNY Investment Advisers sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 31,500 shares — an estimated $1.7M sold.
FNY Investment Advisers first reported a position in BMY in Q3 2020 and held it in 18 quarters. The position peaked at $1.7M in Q4 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- FNY Investment Advisers reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- FNY Investment Advisers sold 31,500 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.7M.
- FNY Investment Advisers first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 18 quarters.
- FNY Investment Advisers's Bristol-Myers Squibb position peaked at $1.7M in Q4 2025.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on FNY Investment Advisers's 13F filing for Q1 2026, filed 15 Apr 2026.